Korro Bio, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Korro Bio, Inc. (KRRO) had Common Stock, Capital Shares Reserved for Future Issuance of 6.09 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 6.09M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 6.27M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.57M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 2.59M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 6.09M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 6.27M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 2.57M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 2.59M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 2.59M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 2.60M shares 10-Q · filed 2025-05-07 | |
| 2024-12-31 | 2.04M shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 2.10M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 2.14M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 2.15M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 1.68M shares 10-K · filed 2025-03-18 | |
| 2023-09-30 | 7.68M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 7.46M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 7.29M shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 5.49M shares 10-K · filed 2024-03-26 | 6.73M shares 10-K · filed 2023-03-10 |
| 2022-09-30 | 6.73M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 7.77M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 7.91M shares 10-Q · filed 2022-05-04 | |
| 2021-12-31 | 8.38M shares 10-K · filed 2023-03-10 | |
| 2021-09-30 | 8.37M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 9.23M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 9.40M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 8.29M shares 10-K · filed 2022-03-15 | |
| 2020-09-30 | 8.52M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 8.66M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 8.90M shares 10-Q · filed 2020-05-14 | |
| 2019-12-31 | 7.83M shares 10-K · filed 2021-03-29 | |
| 2019-09-30 | 29.96M shares 10-Q · filed 2019-11-18 | |
| 2018-12-31 | 19.29M shares 10-K · filed 2020-03-26 | |
| 2017-12-31 | 10.92M shares 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |